Actively Recruiting

Phase Not Applicable
Age: 1Year - 18Years
All Genders
NCT05310799

Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA

Led by University of British Columbia · Updated on 2023-12-06

842

Participants Needed

1

Research Sites

297 weeks

Total Duration

On this page

Sponsors

U

University of British Columbia

Lead Sponsor

C

Canadian Institutes of Health Research (CIHR)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The PERSON-JIA Trial is a cluster-randomized trial testing the use of Shared Decision Making (SDM) with families for treatment of children with arthritis. The intervention is a discussion between physicians and families at the time of diagnosis that uses computer-generated personalized outcome reports generated by previously developed prediction algorithms. By using information provided by thousands of families, the investigators have developed a way of providing answers to common questions asked by patients and their families at diagnosis. We will test whether a structured discussion and shared decision between families and doctors (guided by the patient's personal report) will improve the tailoring of treatment to the child and control of their disease. The personal report is called the PERSON-JIA report and presents the child's expected disease severity, the likelihood the child will be arthritis free by age 18 and the chance treatments will be effective and/or have side effects. This way, answers to these questions can be shared by physicians and families to weigh potential benefits and harms according to family values and preferences. The investigators expect that using the personalized report in a frank and thoughtful discussion will help physicians and families make better decisions about managing the child's disease. This in turn will result in better disease control, greater family engagement and satisfaction with care and better-tailored treatment. If so, this will be a ground-breaking way of using information provided by families and doctors to improve the care provided to and the outcomes of children with arthritis in Canada.

CONDITIONS

Official Title

Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA

Who Can Participate

Age: 1Year - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Consent to include their information in the CAPRI JIA Registry
  • Consent to participate in the PERSON-JIA trial and complete additional questionnaires
  • Agree to allow recording of their medical visit if randomly selected
  • Diagnosis of Juvenile Idiopathic Arthritis (JIA) following ILAR criteria
  • Newly diagnosed with JIA within the last month
  • Diagnosed by a pediatric rheumatologist participating in this study
  • Not yet started treatment or only treated with NSAIDs or joint injections
Not Eligible

You will not qualify if you...

  • Diagnosed with systemic arthritis category of JIA
  • Family unable to complete study forms in English or French
  • Already started systemic corticosteroids or any Disease Modifying Anti-Rheumatic Drugs (DMARDs)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

BC Children's Hospital

Vancouver, British Columbia, Canada, V6H 3N1

Actively Recruiting

Loading map...

Research Team

J

Jaime Guzman

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here